Effects of human globin transgene expression on β-thalassemic erythropoiesis
Mice . | Human globin/murine α† . | Hb, g/dL . | MCH, pg . | RDW . | Retic, % . | Spleen, mg . |
---|---|---|---|---|---|---|
THAL | NA | 9.13 ± 0.13 | 12.9 ± 0.27 | 33.3 ± 0.66 | 21.8 ± 1.5 | 392 ± 35 |
Strain A | 0.03 | 9.77 ± 0.11* | 13.9 ± 0.47 | 31.0 ± 0.67* | 20.6 ± 1.3 | 406 ± 52 |
Strain B | 0.07 | 11.2 ± 0.12* | 14.1 ± 0.31* | 29.6 ± 0.54* | 14.0 ± 1.3* | 208 ± 33* |
Strain C | 0.13 | 12.4 ± 0.60* | 14.9 ± 0.44* | 24.5 ± 0.72* | 7.70 ± 1.4* | 125 ± 13* |
Strain D | 0.38 | 13.9 ± 0.31* | 15.1 ± 0.26* | 19.2 ± 0.69* | 1.95 ± 0.22* | 113 ± 6* |
WT | NA | 14.5 ± 0.13* | 16.7 ± 0.17* | 18.5 ± 0.20* | 1.75 ± 0.25* | 99 ± 8* |
Mice . | Human globin/murine α† . | Hb, g/dL . | MCH, pg . | RDW . | Retic, % . | Spleen, mg . |
---|---|---|---|---|---|---|
THAL | NA | 9.13 ± 0.13 | 12.9 ± 0.27 | 33.3 ± 0.66 | 21.8 ± 1.5 | 392 ± 35 |
Strain A | 0.03 | 9.77 ± 0.11* | 13.9 ± 0.47 | 31.0 ± 0.67* | 20.6 ± 1.3 | 406 ± 52 |
Strain B | 0.07 | 11.2 ± 0.12* | 14.1 ± 0.31* | 29.6 ± 0.54* | 14.0 ± 1.3* | 208 ± 33* |
Strain C | 0.13 | 12.4 ± 0.60* | 14.9 ± 0.44* | 24.5 ± 0.72* | 7.70 ± 1.4* | 125 ± 13* |
Strain D | 0.38 | 13.9 ± 0.31* | 15.1 ± 0.26* | 19.2 ± 0.69* | 1.95 ± 0.22* | 113 ± 6* |
WT | NA | 14.5 ± 0.13* | 16.7 ± 0.17* | 18.5 ± 0.20* | 1.75 ± 0.25* | 99 ± 8* |
Values represent the mean and SEM.
THAL indicates thalassemic; WT, wild type; Hb, hemoglobin; MCH, mean corpuscular hemoglobin; RDW, red cell distribution width; retic, reticulocyte; Spleen, splenic weight; NA, not applicable.
Statistically significant difference from THAL with P of at least < .006.
Ratio of human γ-globin (strains A, B, and C) or human β-globin (strain D) messenger RNA to total mouse α-globin messenger RNA.